SCHEMBL6283769

SCHEMBL6283769

CCCCCCCCC=CCCCCCCC(C)C(N)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.59
SOAT1 P35610 2/20 0.59
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 2/20 0.59
MEN1 O00255 1/20 0.59
TP53 P04637 1/20 0.59
CYP3A4 P08684 1/20 0.59
KMT2A Q03164 1/20 0.59
KDM4E B2RXH2 2/20 0.59
CNR1 P21554 1/20 0.56
DUSP3 P51452 2/20 0.50
TERT O14746 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
APEX1 P27695 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9238140 1.00 FAAH (0.59) FAAHSOAT1CYP1A2CYP2C19MEN1
SCHEMBL20303229 1.00 FAAH (0.59) FAAHSOAT1CYP1A2CYP2C19MEN1
SCHEMBL379106 1.00 FAAH (0.59) FAAHSOAT1CYP1A2CYP2C19MEN1
SCHEMBL10800485 1.00 FAAH (0.59) FAAHSOAT1CYP1A2CYP2C19MEN1
SCHEMBL18248554 0.97 KDM4E (0.65) FAAHSOAT1CYP1A2CYP2C19MEN1
SCHEMBL29689655 0.97 KDM4E (0.65) FAAHSOAT1CYP1A2CYP2C19MEN1
SCHEMBL28504984 0.97 KDM4E (0.65) FAAHSOAT1CYP1A2CYP2C19MEN1
SCHEMBL23857835 0.89 CA1 (0.59) TP53MAPT
SCHEMBL10866301 0.89 CA1 (0.59) TP53MAPT
SCHEMBL13854594 0.89 CA1 (0.59) TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120077056-A BRINP 2-derived peptide compositions for the treatment of obesity and weight control 利兰斯坦福初级大学董事会 2025-05-30 CN disclosed
EP-3386484-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS ModernaTX, Inc. (US) 2018-10-17 EP disclosed
EP-3297621-A1 A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE Dublin City University (IE) 2018-03-28 EP disclosed
WO-2017099823-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS MODERNATX, INC. (US) 2017-06-15 WO disclosed
WO-2016185025-A1 A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE DUBLIN CITY UNIVERSITY (IE) 2016-11-24 WO disclosed
WO-2014117099-A2 THERMOCHROMIC COLORING PAD CHROMATIC TECHNOLOGIES INC. (US) 2014-07-31 WO disclosed
CN-1930006-B Developer mixture for thermal recording materials and thermal recording materials API CORP 2010-12-08 CN disclosed
CN-1930006-A Developer mixture for thermal recording materials and thermal recording materials API CORP (JP) 2007-03-14 CN disclosed
US-6852315-B2 Epoxidation of carbon-carbon double bond with membrane bound peroxygenase THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2005-02-08 US disclosed
US-20030040090-A1 Epoxidation of carbon-carbon double bond with membrane bound peroxygenase AGRICULTURE, UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY 2003-02-27 US disclosed
US-6485949-B1 Epoxidation of carbon-carbon double bond with membrane bound peroxygenase THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE 2002-11-26 US disclosed
CN-1054507-C Improved intravaginal treatment of vaginal infections with buffered metranidazole compositions CURATEK PHARMACEUTICALS LTD PA (US) 2000-07-19 CN disclosed
US-5471234-A Recording apparatus RICOH COMPANY, LTD. (JP) 1995-11-28 US disclosed
US-5278126-A Selectively heating the surface RICOH COMPANY, LTD. (JP) 1994-01-11 US disclosed
CN-1049101-A Improved with the method for buffering metronidazole compositions at intravaginal treatment vaginal infection CURATEK PHARMACEUTICALS LTD PA (US) 1991-02-13 CN disclosed
EP-0403833-A2 Recording material NEW OJI PAPER CO., LTD. (JP) 1990-12-27 EP disclosed
US-4716175-A INHIBITION OF INTESTINAL ABSORPTION OF CHOLESTEROL WARNER-LAMBERT COMPANY (US) 1987-12-29 US disclosed
EP-0208921-A2 Hydroformylation of olefinic compounds in the presence of soluble cobalt salt catalysts and an organic nitrile promoter HENKEL CORPORATION (a Delaware corp.) (US) 1987-01-21 EP disclosed